GSS — Genetic Signatures Share News
0.000.00%
Last trade - 00:00- AU$19.31m
- -AU$2.48m
- AU$20.32m
Brief: Genetic Signatures Announces Strategic Partnership With Tecan And Repado
Brief: Genetic Signatures Reports Quarterly Sales Of A$4.4 Million
Brief: Genetic Signatures Logs Loss For Half-Year Attributable A$15.2 Mln
Brief: Genetic Signatures Posts Qtrly Sales Of A$4.7 Mln
Australian pharma firm Genetic Signatures gains as Bell Potter lifts PT
Australia's Genetic Signatures jumps on US FDA nod for diagnosis kit
Brief: US FDA Clearance For Genetic Signatures' Gastrointestinal Parasite Detection Kit
Brief: Genetic Signatures Announces A$30 Mln Capital Raising
Brief: Genetic Signatures Appoints Allison Rossiter As CEO
Brief: Genetic Signatures Says FDA Clearance For Gastrointestinal Parasite Detection Kit
Brief: Genetic Signatures Seeks Trading Halt
Brief: Genetic Signatures Says Decision To Cease Development Of US Respiratory Product
Brief: Genetic Signatures Says John Melki Stepped Down As CEO
Brief: Genetic Signatures Posts Qtrly Sales Of A$1.7 Mln
Brief: Genetic Signatures Says TGA Authorises Supply Of Updated Respiratory Detection Kit
Brief: Genetic Signatures Posts HY Loss Attributable Up 62% To A$10.5 Mln
Brief: Genetic Signatures Posts Sales (Unaudited) For Q2 Of Fy2024
Brief: Genetic Signatures Announces A$15.9M Capital Raising
Australia's Genetic Signatures hits nearly 5-1/2-year low on discounted capital raise